Background: In a prior study of our group we found an up-regulation of CD46 expression in a cohort of Spanish multiple sclerosis (MS) patients.
Objective: To evaluate the potential role of CD46 in the response to interferon-beta treatment in MS patients through the analysis of five tagging single nucleotide polymorphisms (SNPs) and measurement of mRNA.
Methods: A total of 406 MS patients and 513 control patients were analysed for five SNPs at the CD46 locus. Furthermore, 163 MS patients and 163 matched control patients were analysed by RT-PCR for the CD46 mRNA expression in three blood samples (basal, and at 6 and 12 months of interferon-beta treatment) collected in the course of a 1-year follow-up.
Results: Two genotypes of rs2724385 polymorphism (AT and TT) could be markers of response to interferon-beta therapy in MS patients (p = 0.007 and p = 0.006, respectively). Furthermore, the frequency of interferon-beta responders was 44.4% (32/72) in MS patients with an increased CD46 mRNA expression, vs. 65.9% (60/91) in patients with a decreased CD46 mRNA expression (p = 0.006).
Conclusion: The present study shows that CD46 could be associated with the response to interferon-beta therapy; however, the genetic results should be replicated in an independent cohort and further studies are needed to confirm the role of CD46.
SantoroFKennedyPELocatelliGMalnatiMSBergerEALussoP. CD46 is a cellular receptor for human herpesvirus 6. Cell1999; 99: 817–827.
2.
Alvarez-LafuenteRDe Las HerasVBartolomeMGarcia-MontojoMArroyoR. Human herpesvirus 6 and multiple sclerosis: A one-year follow-up study. Brain Pathol2006; 16: 20–27.
3.
FotheringhamJJacobsonS. Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease. Herpes2005; 12: 4–9.
4.
PietiläinenJVirtanenJOUotilaLSalonenOKoskiniemiMFärkkiläM. HHV-6 infection in multiple sclerosis. A clinical and laboratory analysis. Eur J Neurol2009, DOI: 10.1111/j.1468-1331.2009.02718.x.
5.
Fogdell-HahnASoldanSSShueSAkhyaniNRefaiHAhlqvistJ. Co-purification of soluble membrane cofactor protein (CD46) and human herpesvirus 6 variant A genome in serum from multiple sclerosis patients. Virus Res2005; 110: 57–63.
6.
KemperCChanACGreenJMBrettKAMurphyKMAtkinsonJP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature2003; 421: 388–392.
7.
AstierALMeiffrenGFreemanSHaflerDA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest2006; 116: 3252–3257.
Vaknin-DembinskyABalashovKWeinerHL. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol2006; 176: 7768–7774.
10.
Vaknin-DembinskyAMurugaiyanGHaflerDAAstierALWeinerHL. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J Neuroimmunol2008; 195: 140–145.
11.
ShustaEVZhuCBoadoRJPardridgeWM. Subtractive expression cloning reveals high expression of CD46 at the blood–brain barrier. J Neuropathol Exp Neurol2002; 61: 597–604.
12.
Alvarez-LafuenteRGarcia-MontojoMDe Las HerasVDominguez-MozoMIBartolomeMArroyoR. CD46 expression and HHV-6 infection in patients with multiple sclerosis. Acta Neurol Scand2009; 120: 246–250.
13.
WaubantEGoodkinDEGeeLBacchettiPSloanRStewartT. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology1999; 53: 1397–1401.
14.
YenJHKongWGaneaD. IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J Immunol2010; 184: 3478–3486.
15.
PoserCMPatyDWScheinbergLMcDonaldWIDavisFAEbersGC. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol1983; 13: 227–231.
16.
McDonaldWIFazekasFThompsonAJ. [Diagnosis of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova2003; 2: 4–9.
17.
PachnerARNarayanKPriceNHurdMDailD. MxA gene expression analysis as an interferon-beta bioactivity measurement in patients with multiple sclerosis and the identification of antibody-mediated decreased bioactivity. Mol Diagn2003; 7: 17–25.
18.
PollardAJFlanaganBFNewtonDJJohnsonPM. A novel isoform of human membrane cofactor protein (CD46) mRNA generated by intron retention. Gene1998; 212: 39–47.
19.
SeyaTHaraTIwataKKuriyamaSHasegawaTNagaseY. Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera. Int Immunol1995; 7: 727–736.
20.
SzalmásAKónyaJSziklaiIKarosiT. Detection and identification of CD46 splicing isoforms by nested RT-PCR. Methods Mol Biol2010; 630: 83–95.
